Immutep Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Immutep Contact Number

Thank you for your interest in Immutep and the cancer and autoimmune treatments made possible by our Lag-3 technology.For media requests, or to contact the Immutep team regarding partnerships, email [email protected]immutep.com and a member of our support team will direct your inquiry.

Contact US: https://www.immutep.com/contacts/contact.html

How can i contact the immutep media team?

For media requests, or to contact the Immutep team regarding partnerships, email [email protected] and a member of our support team will direct your inquiry. You may automatically receive Electronic Communications by e-mail, please sign up here.

What do you need to know about immutep lag 3?

Thank you for your interest in Immutep and the cancer and autoimmune treatments made possible by our Lag-3 technology. For media requests, or to contact the Immutep team regarding partnerships, email [email protected] and a member of our support team will direct your inquiry.

What is the fda fast track designation for immutep?

Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer Whats next. About us. passion. It takes a great deal of passion on the fight against cancer. We put our heart and soul into winning it. know-how.

Immutep’s

53 People Used

See More ››

Immutep

Immutep’s phone number is +61 2 8315 7003 What is Immutep’s stock symbol? Immutep’s stock symbol is IMMP What is Immutep’s official website?

View Contact ››

2021

27 People Used

See More ››

LAG 3

Immutep Reports Positive Final Data from the INSIGHT-004 Phase I Study of LAG-3 Therapy, Efti, at ASCO 2021. June 4th 2021. press releases. more.

View Contact ››

Receive

67 People Used

See More ››

Immutep Shareholder Updates & Announcements

Request the Immutep Shareholder Newsletter below to receive updates and announcements by e-mail. Simply enter your name and email address, and select the authorization field to receive operational updates and select regulatory filings as they become available. Questions? Contact Immutep.

View Contact ››

Confirmation

63 People Used

See More ››

Confirmation

Confirmation. Many thanks for your message. We will respond to you as soon as possible.

View Contact ››

Phone

53 People Used

See More ››

Immutep

Phone Number +33169289992 Immutep is a biopharmaceutical company developing immunotherapeutics in oncology. Their products include a T cell immunostimulatory factor (APC activator) for cancer chemo-immunotherapy and a therapeutic antibody for immune response modulation in cancer.

View Contact ››

Increased

31 People Used

See More ››

Immutep Company Profile

Immutep has 1.73k Twitter Followers. The number of followers has increased 0.5% month over month and increased 3.1% quarter over quarter

View Contact ››

Governance

76 People Used

See More ››

Immutep Corporate Governance Practices & Conduct Code

The Corporate Governance Statement sets out the extent to which the Company has followed the recommendations of the ASX Corporate Governance Council''s Corporate Governance Principles and Recommendations for the year ending 30 June 2019.

View Contact ››

Immutep

42 People Used

See More ››

Immutep Limited

Immutep Limited. August 31 at 8:06 PM ·. The Australian Research Council (ARC) has awarded Immutep Limited and research partner Monash University a A$671k grant under the ARC‘s Linkage Project scheme to support their research collaboration into Lymphocyte Activation Gene-3 (LAG-3) for a further three years.

View Contact ››

Receive

44 People Used

See More ››

Rockstar Games Customer Support

Receive help with your Rockstar Games technical issues – Use our Knowledge Base Articles and receive assistance via Callback, Chat, Email, and our Player Supported Community

View Contact ››

Summary

56 People Used

See More ››

Immutep Limited (IMMP) Company Profile & Facts

See the company profile for Immutep Limited (IMMP) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

View Contact ››

Sydney

57 People Used

See More ››

IMMP

Sydney, AUSTRALIA, June 21, 2021 (GLOBE NEWSWIRE) -- Immutep Limited ((ASX: IMM, NASDAQ:IMMP) (Immutep or Company), is pleased to announce that it has received commitments for a A$60 million two-tranche private placement of new ordinary shares (New Shares) to professional, institutional and sophisticated investors (Placement). The first tranche of the Placement will be …

View Contact ››

Which

60 People Used

See More ››

Immutep Company Profile: Stock Performance & Earnings

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti

View Contact ››

Immutep

128 People Used

See More ››

Immutep Granted European Patent for IMP761

Immutep CEO, Marc Voigt stated: “IMP761 is the first agonist antibody that targets the immune checkpoint LAG-3 and aims to treat the root cause of …

View Contact ››

Please leave your comments here:

Popular Brands

Intel
Icbc
Iqvia
Isbank
Itc
Ing
Ipg
Igt
Imcd
Idex